Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes (ROOTS)

Novo Nordisk

Status: Completed

Conditions: Diabetes; Diabetes Mellitus, Type 2

Treatments: Drug: liraglutide

Study type: Observational

Funder types: Industry

Identifiers

NCT01288326

NN2211-3876

U1111-1116-2199 (Other Identifier)

Details and patient eligibility

About

The study is conducted in Europe. The aim of this observational study is to assess glycaemic control while using liraglutide under normal clinical practice conditions in Belgium.

Enrollment: 254 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Type 2 diabetes
• Insufficiently controlled after 3 months of treatment with OADs (oral anti-diabetic drugs)

Exclusion criteria

• Previously treated with liraglutide
• Hypersensitivity to liraglutide or to any of the excipients (Disodium phosphate dihydrate, propylene glycol, phenol, water for injections)
• Pregnant, breast feeding or have the intention of becoming pregnant

Trial design

254 participants in 1 patient group

A

Treatment:

Drug: liraglutide